VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ)

$16.36 0.22 (1.3631%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 88

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ) News Sources

How This Amgen Rival, Up 33%, Plans To Shake Its Grip In Thyroid Eye Disease

05-05-2026

yahoo.com

external link

Viridian (VRDN) Climbs 33% on Looming Drug Commercialization

06-05-2026

yahoo.com

external link

Viridian Therapeutics REVEAL-2 Hits Phase 3 Endpoint, Shows “IV-like” Proptosis Gains in Chronic TED

06-05-2026

marketbeat.com

external link

Viridian Therapeutics’ stock up 35% after Phase III TED data release

06-05-2026

clinicaltrialsarena.com

external link

Viridian Therapeutics Announces Pricing of Upsized Concurrent Public Offerings of 1.75% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $350.0 Million

07-05-2026

yahoo.com

external link

Earnings Update: Viridian Therapeutics, Inc. (NASDAQ:VRDN) Just Reported And Analysts Are Boosting Their Estimates

07-05-2026

yahoo.com

external link

Why Viridian Therapeutics (VRDN) Is Up 25.9% After Phase 3 Elegrobart Win And Fresh Fundraising

08-05-2026

yahoo.com

external link

This Biotech Has a June 30 FDA Catalyst. A Fund Just Cut Its Stake by $7 Million

17-05-2026

fool.com

external link

Viridian Therapeutics (VRDN) Prices Upsized Concurrent Public Offerings Totaling $350M

21-05-2026

yahoo.com

external link

Viridian Therapeutics to Participate in Upcoming June Investor Conferences

27-05-2026

yahoo.com

external link

VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ) Sentiment Trend

0 25 50 75 100 85 89 80 90 84 87 92 90 93 90 05-05-2026 06-05-2026 07-05-2026 08-05-2026 17-05-2026 21-05-2026 27-05-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ) FAQs

toggle

What is the current price of VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ)?

The current price of VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ) is $16.36.


toggle

VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ) absolute price change since previous trading day?

The absolute price change of VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ) since the previous trading day is $0.22.


toggle

VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ) percentage price change since previous trading day?

The percentage price change of VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ) since the previous trading day is 1.3631%.


toggle

What is the most recent average sentiment score for VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ)?

The most recent average sentiment score for VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ) is 88 out of 100.


toggle

What is the most recent average sentiment for VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ)?

The most recent sentiment for VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ) is .


SEC-8K** Filing Available For VIRIDIAN THERAPEUTICS INC (VRDN:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Similar Securities People Also Ask

VRPX (Virpax Pharmaceuticals Inc)
VRAX (Virax Biolabs Group Limited)
VRCA (Verrica Pharmaceuticals Inc)

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.